More articles from Cell Fate Decisions

The Zinc-Finger AN1-Type Domain 2a Gene Acts as a Regulator of Cell Survival in Human Melanoma: Role of E3-Ligase cIAP2
Sofia Pizzato Scomazzon, Anna Riccio, Silvia Santopolo, Giulia Lanzilli, Marta Coccia, Antonio Rossi, M. Gabriella Santoro

Molecular Cancer Research Dec 2019, 17 (12) 2444-2456; DOI: 10.1158/1541-7786.MCR-19-0243
Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814
Qing Sun, Yige Guo, Xiaohong Liu, Frank Czauderna, Michael I. Carr, Frank T. Zenke, Andree Blaukat, Lyubomir T. Vassilev

Molecular Cancer Research Dec 2019, 17 (12) 2457-2468; DOI: 10.1158/1541-7786.MCR-19-0362
Sophoridine Inhibits Human Colorectal Cancer Progression via Targeting MAPKAPK2
Rui Wang, Hongwei Liu, Yingying Shao, Kailong Wang, Shuangshuang Yin, Yuling Qiu, Honghua Wu, Erwei Liu, Tao Wang, Xiumei Gao, Haiyang Yu

Molecular Cancer Research Dec 2019, 17 (12) 2469-2479; DOI: 10.1158/1541-7786.MCR-19-0553
A TAZ–ANGPTL4–NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer
Wen-Hsuan Yang, Zhiqing Huang, Jianli Wu, Chien-Kuang C. Ding, Susan K. Murphy, Jen-Tsan Chi

Molecular Cancer Research Oct 2019, DOI: 10.1158/1541-7786.MCR-19-0691
ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State
Adam Kosti, Liqin Du, Haridha Shivram, Mei Qiao, Suzanne Burns, Juan Gabriel Garcia, Alexander Pertsemlidis, Vishwanath R. Iyer, Erzsebet Kokovay, Luiz O.F. Penalva

Molecular Cancer Research Oct 2019, DOI: 10.1158/1541-7786.MCR-19-0187
CD71⁺ Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Thomas Ho-Yin Leung, Hermit Wai-Man Tang, Michelle Kwan-Yee Siu, David Wai Chan, Karen Kar-Loen Chan, Annie Nga-Yin Cheung, Hextan Yuen-Sheung Ngan

Molecular Cancer Research Sep 2019, 17 (9) 1867-1880; DOI: 10.1158/1541-7786.MCR-19-0068
HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity
Basmina Parmakhtiar, Robert A. Burger, Jai-Hyun Kim, John P. Fruehauf

Molecular Cancer Research Aug 2019, 17 (8) 1675-1686; DOI: 10.1158/1541-7786.MCR-18-1109
Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/C^CDH1 Activity and Pharmacologic Inhibition of APC/C^CDH1/CDC20 Compromises Viability
Kuntal De, Treg M. Grubb, Abigail A. Zalenski, Kayla E. Pfaff, Debjani Pal, Shubhra Majumder, Matthew K. Summers, Monica Venere

Molecular Cancer Research Jul 2019, 17 (7) 1519-1530; DOI: 10.1158/1541-7786.MCR-18-1361
GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer
Samantha M. Bevill, Jose F. Olivares-Quintero, Noah Sciaky, Brian T. Golitz, Darshan Singh, Adriana S. Beltran, Naim U. Rashid, Timothy J. Stuhlmiller, Andrew Hale, Nathaniel J. Moorman, Charlene M. Santos, Steven P. Angus, Jon S. Zawistowski, Gary L. Johnson

Molecular Cancer Research Jul 2019, 17 (7) 1503-1518; DOI: 10.1158/1541-7786.MCR-18-1121
MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Jiujie Cui, Zhuqing Zhou, Haiyan Yang, Feng Jiao, Ning Li, Yong Gao, Liwei Wang, Jingde Chen, Ming Quan

Molecular Cancer Research Jun 2019, 17 (6) 1316-1325; DOI: 10.1158/1541-7786.MCR-18-0910

Main menu

User menu

Search

More articles from Cell Fate Decisions

Pages

Articles

Information for

About MCR